Surgery Partners, Inc. (NASDAQ:SGRY – Get Free Report) shares fell 3.7% on Tuesday . The stock traded as low as $20.38 and last traded at $20.38. 41,930 shares changed hands during mid-day trading, a decline of 94% from the average session volume of 758,644 shares. The stock had previously closed at $21.16.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on the company. Bank of America started coverage on Surgery Partners in a report on Monday, December 16th. They issued a “buy” rating and a $30.00 price target for the company. JPMorgan Chase & Co. decreased their price target on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research note on Tuesday, December 3rd. Royal Bank of Canada cut their price objective on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 20th. UBS Group began coverage on shares of Surgery Partners in a research report on Monday, October 14th. They issued a “buy” rating and a $38.00 target price for the company. Finally, Macquarie restated an “outperform” rating and set a $34.00 price objective on shares of Surgery Partners in a research note on Tuesday, November 19th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $36.56.
View Our Latest Stock Report on SGRY
Surgery Partners Stock Performance
Surgery Partners (NASDAQ:SGRY – Get Free Report) last posted its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business had revenue of $770.40 million during the quarter, compared to the consensus estimate of $768.99 million. The business’s revenue for the quarter was up 14.3% on a year-over-year basis. During the same period in the prior year, the firm earned $0.15 EPS. Equities analysts anticipate that Surgery Partners, Inc. will post 0.71 EPS for the current year.
Institutional Trading of Surgery Partners
Several large investors have recently bought and sold shares of the business. FMR LLC lifted its position in shares of Surgery Partners by 3.1% during the 3rd quarter. FMR LLC now owns 18,311,867 shares of the company’s stock valued at $590,375,000 after buying an additional 546,869 shares during the last quarter. Clearbridge Investments LLC boosted its holdings in shares of Surgery Partners by 1.3% in the 2nd quarter. Clearbridge Investments LLC now owns 5,585,530 shares of the company’s stock worth $132,880,000 after purchasing an additional 73,007 shares during the period. Janus Henderson Group PLC raised its stake in Surgery Partners by 27.5% in the third quarter. Janus Henderson Group PLC now owns 5,497,368 shares of the company’s stock valued at $177,235,000 after buying an additional 1,184,450 shares during the last quarter. Deerfield Management Company L.P. Series C raised its position in Surgery Partners by 47.7% during the second quarter. Deerfield Management Company L.P. Series C now owns 4,707,287 shares of the company’s stock worth $111,986,000 after acquiring an additional 1,520,484 shares during the period. Finally, Dimensional Fund Advisors LP lifted its position in shares of Surgery Partners by 26.7% during the second quarter. Dimensional Fund Advisors LP now owns 2,801,091 shares of the company’s stock worth $66,643,000 after purchasing an additional 589,499 shares in the last quarter.
Surgery Partners Company Profile
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Read More
- Five stocks we like better than Surgery Partners
- What Investors Need to Know to Beat the Market
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- Top Stocks Investing in 5G Technology
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.